Skip to main content
. 2023 Jul 10;38(14):3224–3234. doi: 10.1007/s11606-023-08297-y

Table 2.

Overall Homogeneous Association Between ACP Billing and Exposure to the Intervention Estimated using a Mixed-effects Model that Simultaneously Adjusted for Time, Patient Characteristics, and Hospital Characteristics. The Model Adjusted for the Variables Listed in the Table as well as Time (Month and day of Admission)

Variable Odds ratio with 95% confidence intervals p value
Intervention 0.96 (0.88–1.06) 0.42
Step of the trial
  One Referent
  Two 1.05 (0.61–1.82) 0.85
  Three 0.97 (0.53–1.77) 0.92
  Four 1.11 (0.61–2.00) 0.74
  Five 1.11 (0.65–1.92) 0.70
Patient age
  65–74 years Referent
  75–84 years 1.47 (1.39–1.55)  < 0.001
   ≥ 85 years 2.15 (2.02–2.29)  < 0.001
Covid status
  Covid positive Referent
  Covid negative 0.70 (0.66–0.76)  < 0.001
Coronary artery disease 1.01 (0.93–1.09) 0.87
Heart failure 1.12 (1.00–1.25) 0.05
Dementia 1.02 (0.87–1.18) 0.84
COPD 1.35 (1.25–1.47)  < 0.001
Diabetes 1.09 (0.93–1.27) 0.28
Charlson score
  Zero Referent
  One 0.95 (0.88–1.02) 0.17
  Two 1.18 (1.11–1.27)  < 0.001
  Three 1.17 (1.07–1.29) 0.001
  Four 1.20 (1.05–1.36) 0.008
  Five 1.51 (1.31–1.74)  < 0.001
Would you be surprised if the patient died in the next year
  Yes Referent
  No 1.64 (1.56–1.73)  < 0.001
Region
  South Referent
  Midwest 0.62 (0.34–1.14) 0.13
  West 1.18 (0.55–2.51) 0.68
Practice size 1.03 (1.00–1.07) 0.07
Proportion of hospitalizations with COVID 0.75 (0.47–1.19) 0.22
ACP rate in Quarter 2 of 2020 (effect of a 10 percentage-point increase) 1.41 (1.08–1.85) 0.01
Change in ACP rate between Q2 of 2019 and Q1 of 2020 1.55 (0.03–73.10) 0.82